Tata Elxsi Q1-FY25 Earnings Analysis

Tanushree Jaiswal Tanushree Jaiswal

Last Updated: 12th July 2024 - 10:41 am

Listen icon

In first quarter of FY25, Tata Elxsi reported mixed financial results. Despite year-on-year revenue growth, company faced declines in net profit, attributed to higher expenses & increased tax rates. This report provides comprehensive analysis of Tata Elxsi's Q1-FY25 performance, covering key financial metrics, segment-wise performance, & market reactions.

Tata Elxsi Key Financial Metrics

Metric Q1 FY25 Q1 FY24 QoQ Change YoY Change
Revenue from Operations ₹926 crore ₹850 crore 2% 9%
Net Profit ₹184 crore ₹189 crore -6% -3%
Total Expenses ₹706 crore ₹624 crore 13% 13%
EBITDA ₹252 crore ₹252 crore -3% Flat
EBITDA Margin 27.20% N/A -162 bps N/A


Tata ELxsi Detailed Analysis

1. Revenue & Profit

- Revenue from Operations: Tata Elxsi’s revenue grew by 9% year-on-year to ₹ 926 crore from ₹ 850 crore in Q1 FY24. Sequentially, revenue increased by 2% from preceding quarter.

Tata Elexi revenue

- Net Profit: net profit for quarter fell 3% year-on-year to ₹ 184 crore from ₹ 189 crore. Sequentially, net profit decreased by 6% from ₹ 196 crore.

tata elexi pat

2. Expenses & Margins

- Total Expenses: total expenses rose by 13% year-on-year to ₹ 706 crore from ₹ 624 crore.

- EBITDA & Margins: EBITDA for quarter stood at ₹ 252 crore, flat year-on-year but down 3% sequentially. EBITDA margin decreased by 162 basis points quarter-on-quarter to 27.2%.

Segment-Wise Performance

1. Transportation

- Growth: transportation sector reported strong growth of 5% quarter-on-quarter & 20% year-on-year in constant currency.

- Contribution: This segment now accounts for more than 50% of Tata Elxsi’s software development & services business.

- Drivers: growth was driven by significant deal wins & ramp-up of Software Defined Vehicle (SDV) engagements.

2. Media & Communications

- Growth: media & communication business grew 0.9% quarter-on-quarter in actual currency & 0.5% in constant currency.

- Environment: This growth was achieved despite challenging business environment in media & telecom industry.

3. Healthcare & Lifesciences

- Decline: healthcare & lifesciences business saw decline of 4.3% quarter-on-quarter in constant currency.

- Reason: decline was largely due to delays in renewals of some projects with large customer.

4. System Integration Services

- Growth: This segment recorded robust growth of 8.7% quarter-on-quarter in constant currency.

Overview

Market Reaction

- Share Performance: Following results, Tata Elxsi share price  ended at ₹ 7,118.80, up 1.43% on July 10. However, shares fell over 2% in early trade on July 11.

Brokerage Opinions

- Kotak Institutional Equities: Retained Sell call, increasing target price to ₹ 5,500, indicating downside of 22%.

- JPMorgan: Retained Underweight call with price target of ₹ 5,800, implying 18.5% downside. JPMorgan noted positive surprises in transportation sector but anticipated headwinds in healthcare business, leading to cut in earnings estimates by 2-4% over FY25-27 due to higher tax rates.

Tata Elxsi CEO's Commentary

Manoj Raghavan, CEO & Managing Director, highlighted company's operational excellence & fiscal discipline, despite facing exceptional one-off expenses & increased effective tax rates due to changes in SEZ benefits. He expressed confidence in capturing growth opportunities in coming quarters, supported by healthy deal pipeline & continued strength in transportation business.

Tata Elxsi Financials

Metric Q1 FY25 Q1 FY24 QoQ Change YoY Change
Revenue from Operations ₹926 crore ₹850 crore 2% 9%
Net Profit ₹184 crore ₹189 crore -6% -3%
Total Expenses ₹706 crore ₹624 crore 13% 13%
EBITDA ₹252 crore ₹252 crore -3% Flat
EBITDA Margin 27.20% N/A -162 bps N/A
Transportation Growth N/A N/A 5% (QoQ CC) 20% (YoY CC)
Media & Comm. Growth N/A N/A 0.5% (QoQ CC) N/A
Healthcare Decline N/A N/A -4.3% (QoQ CC) N/A
System Integration Growth N/A N/A 8.7% (QoQ CC) N/A

 

Conclusion

Tata Elxsi's Q1 FY25 results reflect balanced performance with significant growth in key segments like transportation, despite challenges in healthcare & lifesciences sectors. company's strategic focus on operational efficiency & disciplined cost management positions it well for future growth, though market reactions & brokerage analyses suggest cautious optimism with anticipated challenges ahead.
 

How do you rate this article?
Characters remaining (1500)

FREE Trading & Demat Account
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
hero_form

Fundamental & Technical Analysis Related Articles

Stock in Action - Apollo Tyres

by Tanushree Jaiswal 15th Jul 2024

Stock in Action – MPhasis

by Tanushree Jaiswal 12th Jul 2024

Stock in Action – Raymond

by Tanushree Jaiswal 11th Jul 2024

Stock in Action –RVNL

by Tanushree Jaiswal 10th Jul 2024

Stock in Action – Marico

by Tanushree Jaiswal 8th Jul 2024

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Want to Use 5paisa
Trading App?